AU7526494A - Method of inhibiting kaposi's sarcoma - Google Patents

Method of inhibiting kaposi's sarcoma

Info

Publication number
AU7526494A
AU7526494A AU75264/94A AU7526494A AU7526494A AU 7526494 A AU7526494 A AU 7526494A AU 75264/94 A AU75264/94 A AU 75264/94A AU 7526494 A AU7526494 A AU 7526494A AU 7526494 A AU7526494 A AU 7526494A
Authority
AU
Australia
Prior art keywords
apoe
cells
kaposi
sarcoma
apolipoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75264/94A
Other languages
English (en)
Inventor
Philip J Browning
Robert C. Gallo
Amos Panet
David D. Roberts
Tikva Vogel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Savient Pharmaceuticals Inc
Original Assignee
Bio Tech General Corp
United States, Represented By Secretary
Savient Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Tech General Corp, United States, Represented By Secretary, Savient Pharmaceuticals Inc filed Critical Bio Tech General Corp
Publication of AU7526494A publication Critical patent/AU7526494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Amplifiers (AREA)
AU75264/94A 1993-08-12 1994-08-12 Method of inhibiting kaposi's sarcoma Abandoned AU7526494A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10590093A 1993-08-12 1993-08-12
US105900 1993-08-12
PCT/US1994/009192 WO1995005190A1 (en) 1993-08-12 1994-08-12 Method of inhibiting kaposi's sarcoma

Publications (1)

Publication Number Publication Date
AU7526494A true AU7526494A (en) 1995-03-14

Family

ID=22308419

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75264/94A Abandoned AU7526494A (en) 1993-08-12 1994-08-12 Method of inhibiting kaposi's sarcoma

Country Status (6)

Country Link
EP (1) EP0715521A4 (de)
AU (1) AU7526494A (de)
CA (1) CA2167942A1 (de)
IL (1) IL110638A0 (de)
WO (1) WO1995005190A1 (de)
ZA (1) ZA946090B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA935879B (en) * 1992-08-12 1994-03-11 Bio Technology General Corp Method of inhibiting cell proliferation using apolipoprotein E.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177189A (en) * 1989-08-18 1993-01-05 The Scripps Research Institute Polypeptide analogs of Apolipoprotein E
WO1993000443A1 (en) * 1991-06-26 1993-01-07 Bio-Technology General Corp. Purification of recombinant apolipoprotein e from bacteria
ZA935879B (en) * 1992-08-12 1994-03-11 Bio Technology General Corp Method of inhibiting cell proliferation using apolipoprotein E.

Also Published As

Publication number Publication date
CA2167942A1 (en) 1995-02-23
IL110638A0 (en) 1994-11-11
EP0715521A4 (de) 1998-01-14
EP0715521A1 (de) 1996-06-12
ZA946090B (en) 1995-11-22
WO1995005190A1 (en) 1995-02-23

Similar Documents

Publication Publication Date Title
EP0257406B1 (de) Rekombinanter B-Zell-Differenzierungsfaktor
JP3710815B2 (ja) Ｉｌ−２発現に適したプラスミド
JP3159705B2 (ja) 血管形成ペプチド
RU2292352C9 (ru) Ингибитор и стимулятор пролиферации стволовой клетки и их использование
US5284827A (en) Systemic treatment of metastatic cancer with platelet factor 4
EP0159276A2 (de) Wesentlich gereinigter inhibitorischer Faktor gegen Tumorwachstum
US20050063946A1 (en) Human pluripotent hematopoietic colony stimulating factor, method of production and use
WO2009094850A1 (en) Recombinant ganoderma lucidium immunomodulatory protein (rlz-8) and uses thereof
CN115089698B (zh) 改善皮肤的活性肽与干细胞外泌体在药品或化妆品中的应用
WO1992002240A2 (en) Novel methods and compositions for treatment of angiogenic diseases
WO1995028907A2 (en) Megapoietin: a novel megakaryocyte growth promoting factor
WO1993016716A1 (en) Method and composition for inhibiting angiogenesis
AU625807B2 (en) Uses of recombinant colony stimulating factor-1
AU673543B2 (en) Method of inhibiting cell proliferation using apolipoprotein E
RU2164414C2 (ru) Подавление роста опухолевых клеток эктодоменом синдекана-1
AU6019498A (en) Complexes and combinations of fetuin with therapeutic agents
US5616554A (en) Immune-enhancing agent for therapeutic use in immunocompromised hosts
IE74168B1 (en) Genes coding for a protein having human MACIF activity expression vectors containing said genes transformant cells and proteins having human MACIF activity
CN114983922B (zh) 生物活性肽与干细胞外泌体在皮肤修复中的应用
AU7526494A (en) Method of inhibiting kaposi's sarcoma
Hamon et al. Transforming growth factor-β1 lowers the CD14 content of monocytes
JPH04506818A (ja) 造血細胞の成熟
Armstrong et al. Isolation and initial characterization of tumoricidal monokine (s) from the human monocytic leukemia cell line THP-1
WO1996011700A1 (en) Reduction of mammalian neoplasms with phospholipase a2 activatiing substances
Lane et al. Cytokine production by cholesterol-loaded human peripheral monocyte-macrophages: the effect on fibrinogen mRNA levels in a hepatoma cell-line (HepG2)